Bladder Cancer

1 stories about Bladder Cancer
default image

Cancer Treatment Company Negotiating $20-25 Million Capital Injection

29.10.17|Lilach Baumer
The potential investors condition the investment on delisting BioCanCell from the Tel Aviv Stock Exchange
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1